Which stocks should be picked over the summer? We have sought to answer this question by screening the Stoxx 600 using simple criteria: buy stocks with positive 1m, 3m and 6m EPS revision and that are not expensive (maximum premium of 20% on P/E and P/B) relative to their respective sectors. We have selected stocks on which our analysts have Buy recommendations and our chart analyst (Rémy Colombero) has a positive opinion: Ahold, Aegon, Alten, Arkema, Eiffage and Ipsen. Applying a sym...
>Solid RevPAR trend should continue apace in H2 - Accor has reported solid H1 RevPARs, in line with our expectations at +5.1%, suggesting a slight slowdown in Q2 (North/Central/South America) despite still very solid momentum in all of the group’s main markets (France/Europe at +5.9% and Asia-Pacific at +4.8%). The prospects remain favourable for H2 (support of the tourism segment in France and a more favourable calendar in Germany, for example) despite a base effect ...
Quels titres favoriser pour l’été ? Nous avons tenté de répondre à cette question en criblant sur des critères simples le Stoxx 600 : acheter les titres qui connaissent une dynamique de révision de BPA positive à 1m, 3m et 6m et qui ne sont pas « chers » (prime maximale de 20% en P/E et P/B) par rapport à leurs secteurs de rattachement respectifs. Nous retenons les titres recommandés à l’Achat par nos analystes et pour lesquels notre chartiste (R. Colombero) a une opinion po...
>La solide tendance de RevPAR devrait se poursuivre au S2 - Accor a publié de solides RevPAR au S1, en ligne avec nos attentes à +5.1%, suggérant un léger ralentissement au T2 (Amérique du Nord / Centrale, Amérique du Sud) malgré des dynamiques toujours très solides dans les principaux marchés du groupe (France/Europe à +5,9% et Asie Pacifique à +4.8%). Les perspectives restent bien orientées au S2 (soutien du segment Tourisme en France et calendrier plus favorable en...
>H1 2018 earnings slightly below our expectations, RevPAR in line - H1 2018 sales came to €1,459m, slightly below of our estimates for €1,468m (+3.0% on a reported basis). RevPAR gained 5.1% in H1, in line with our expectations of +5.0%, suggesting a slight slowdown in Q2 to +5.0% after +5.3% in Q1. H1 2018 EBITDA came to €291m, below (-4%) our expectations for €304m, i.e. a 20.0% margin (Oddo BHF 20.7%). This was essentially driven by HotelServices, where the ma...
>H1 2018 earnings slightly below our expectations, RevPAR in line - H1 2018 sales came to €1,459m, slightly below of our estimates for €1,468m (+3.0% on a reported basis). RevPAR gained 5.1% in H1, in line with our expectations of +5.0%, suggesting a slight slowdown in Q2 to +5.0% after +5.3% in Q1. H1 2018 EBITDA came to €291m, below (-4%) our expectations for €304m, i.e. a 20.0% margin (Oddo BHF 20.7%). This was essentially driven by HotelServices, where the ma...
>H1 18 results to be driven by RevPAR growth of 5%e - AccorHotels is due to publish its H1 18 earnings on 26 July before market open. We expect solid RevPAR trends in H1, at +5.0%e, i.e. +4.6%e in Q2, which points to a slight slowdown (+5.3% in Q1) mainly due to South America (+4.0%e in Q2 vs. +13.9% in Q1). In terms of market trends in H1, we expect further decent momentum in France (22% of EBIT) and Europe at 4.8%e (with +5.0% in Q2) as well as in North America (+7....
>Résultats S1 2018 tirés par une croissance de 5%e de RevPAR - AccorHotels publiera ses résultats S1 2018 le 26/07 avant Bourse. Nous attendons une solide tendance de RevPAR au S1, à +5.0%e soit +4.6%e au T2 suggérant un léger ralentissement (+5.3% au T1) principalement lié à l’Amérique du Sud (+4.0%e au T2 vs +13.9% au T1). Par marché au S1, nous anticipons une dynamique toujours bonne en France (22% de l’EBIT) et en Europe à +4.8%e (dont +5.0%e au T2), ainsi qu’en A...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.